Altiora Health Ventures
Long-term value creation through hands-on, operator-led venture investing — built by the people who scaled Europe's leading diagnostics platform.
Investment Philosophy
Altiora Health Ventures is an operator-led initiative investing in European MedTech companies from Seed to Series B. Our founding partners have collectively built, led, and exited across Europe's diagnostics, medtech, and clinical infrastructure landscape.
Target investments are €0.5–3m at entry, with reserves for up to €6m per company and a target ownership of 10–25%. Our primary geography is Europe, with selective North American exposure where portfolio companies require it.
We do not intend to invest passively. We bring clinical validation expertise, regulatory strategy, commercial network access, and operational discipline to every board seat — the same capabilities that built SYNLAB into Europe's leading diagnostics network.
Investment Approach
Investment Focus
We concentrate on areas where operator insight creates durable asymmetry — not broad MedTech generalism.
Founding Partners' Track Record
Our founding partners are personally engaged with a number of early-stage healthcare companies. These are historic and current relationships held by the partners individually, and are not existing investments of Fund I. Specific transfers into the Fund, if any, would be subject to independent valuation, LPAC approval and Luxembourg counsel review.
Fund I is currently in formation and has not yet made any investments. The companies referenced in partner discussions reflect founding partners' individual operating and advisory relationships, offered as evidence of sector experience rather than as a Fund I portfolio.
Fund I
Altiora Health Ventures Fund I is being formed as a Luxembourg vehicle to institutionalize our operator-led investment approach. The fund has not yet held a first close and is not yet operational.
We are engaging prospective institutional LPs ahead of a planned first close. Full fund documentation, including the LPA, ILPA-aligned DDQ, and data room access, is available to qualified institutional investors following an initial conversation.
Final fund structure, regulatory status and AIFM arrangements remain subject to confirmation as formation proceeds.
Institutional Investor Information
The terms below are indicative and reflect current planning for Fund I. They are not final and remain subject to the fund's complete legal documentation. They are presented here for general context and are not sufficient for an investment decision.
| Fund Name | Altiora Health Ventures Fund I |
| Domicile | Luxembourg |
| Structure | Alternative Investment Fund (SCSp) — in formation |
| Target / Hard Cap | €50m / €65m (indicative) |
| Minimum Commitment | €1m (GP discretion) |
| Management Fee | 2.0% on commitments during investment period; on NAV thereafter (indicative) |
| Carried Interest | 20% (indicative) |
| Preferred Return | 8% annual, compounded (indicative) |
| Distribution Waterfall | European (whole-of-fund) |
| GP Commitment | 1% of commitments (indicative) |
| Investment Period | 5 years from final close (planned) |
| Fund Term | 10 years + two 1-year extensions (planned) |
These terms are provided for general informational purposes to prospective institutional investors and do not constitute an offer. Detailed, binding terms are set out exclusively in the fund's final legal documentation, available to qualified LPs under NDA following an initial conversation.
Get in Touch
If you represent an institutional LP and would like to discuss Fund I, we welcome a direct conversation.
This page is intended for qualified institutional investors. Fund I is in formation; no offer or solicitation is made hereby.